Historical salary details - Mr. David E.I. Pyott, M.B.A.,M.D., Member of the Supervisory Board, Koninklijke Philips N.V. - ADR
Mr. David E.I. Pyott, M.B.A.,M.D. is the Member of the Supervisory Board of Koninklijke Philips N.V. - ADR. They also hold 2 other positions in Pliant Therapeutics Inc and Alnylam Pharmaceuticals Inc.
Mr. David E.I. Pyott, M.B.A.,M.D.
Member of the Supervisory Board
$ 155.0 K
Gross Remuneration
-
Current Company
Koninklijke Philips N.V. - ADR
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | 155.0 K | 0.2 % |
| 2024 | Pliant Therapeutics Inc | Independent Director | - | - |
| 2024 | Alnylam Pharmaceuticals Inc | Independent Director | - | - |
| 2023 | Alnylam Pharmaceuticals Inc | Independent Director | 477.2 K | -2.5 % |
| 2023 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 470.4 K | -1.2 % |
| 2023 | Pliant Therapeutics Inc | Independent Director | 275.5 K | 142.5 % |
| 2023 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | 154.8 K | - |
| 2022 | Alnylam Pharmaceuticals Inc | Independent Director | 489.4 K | 4.1 % |
| 2022 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 476.4 K | -1.0 % |
| 2022 | Pliant Therapeutics Inc | Independent Director | 113.6 K | -84.9 % |
| 2022 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | - | - |
| 2021 | Pliant Therapeutics Inc | Independent Director | 754.6 K | - |
| 2021 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 481.1 K | -11.3 % |
| 2021 | Alnylam Pharmaceuticals Inc | Independent Director | 470.0 K | 0.5 % |
| 2021 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | 138.6 K | -10.1 % |
| 2020 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 542.6 K | 19.3 % |
| 2020 | Alnylam Pharmaceuticals Inc | Independent Director | 467.8 K | -0.6 % |
| 2020 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | 154.3 K | -2.7 % |
| 2020 | Pliant Therapeutics Inc | Independent Director | - | - |
| 2020 | Avery Dennison Corp. | Lead Independent Director | - | - |
| 2019 | Alnylam Pharmaceuticals Inc | Independent Director | 470.7 K | -30.0 % |
| 2019 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 454.9 K | -5.2 % |
| 2019 | Avery Dennison Corp. | Lead Independent Director | 298.9 K | 7.8 % |
| 2019 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | 158.5 K | - |
| 2018 | Alnylam Pharmaceuticals Inc | Independent Director | 672.4 K | 20.9 % |
| 2018 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 479.9 K | 7.3 % |
| 2018 | Avery Dennison Corp. | Lead Independent Director | 277.3 K | -2.3 % |
| 2018 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | - | - |
| 2017 | Alnylam Pharmaceuticals Inc | Independent Director | 556.4 K | 9.6 % |
| 2017 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 447.4 K | -42.2 % |
| 2017 | Avery Dennison Corp. | Lead Independent Director | 283.6 K | 2.3 % |
| 2017 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | - | - |
| 2016 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 773.4 K | - |
| 2016 | Alnylam Pharmaceuticals Inc | Independent Director | 507.5 K | -61.2 % |
| 2016 | Avery Dennison Corp. | Lead Independent Director | 277.2 K | 4.7 % |
| 2016 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | - | - |
| 2015 | Alnylam Pharmaceuticals Inc | Director | 1.3 M | - |
| 2015 | Avery Dennison Corp. | Lead Independent Director | 264.7 K | 1.4 % |
| 2015 | Koninklijke Philips N.V. - ADR | Member of the Supervisory Board | - | - |
| 2015 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | - | - |
| 2014 | Avery Dennison Corp. | Lead Independent Director | 261.0 K | 3.4 % |
| 2014 | Edwards Lifesciences Corp | - | 247.6 K | 0.2 % |
| 2014 | Edwards Lifesciences Corp | Independent Director | - | - |
| 2013 | Avery Dennison Corp. | Lead Independent Director | 252.5 K | 3.7 % |
| 2013 | Edwards Lifesciences Corp | Independent Director | 247.0 K | -0.4 % |
| 2012 | Edwards Lifesciences Corp | Independent Director | 248.0 K | 0.8 % |
| 2012 | Avery Dennison Corp. | Lead Independent Director | 243.4 K | -3.7 % |
| 2011 | Avery Dennison Corp. | Lead Independent Director | 252.7 K | 3.9 % |
| 2011 | Edwards Lifesciences Corp | Independent Director | 246.0 K | 13.4 % |
| 2010 | Avery Dennison Corp. | Lead Independent Director | 243.2 K | 52.1 % |
| 2010 | Edwards Lifesciences Corp | Independent Director | 216.9 K | -1.5 % |
| 2009 | Edwards Lifesciences Corp | Director | 220.2 K | 28.2 % |
| 2009 | Avery Dennison Corp. | Director | 159.9 K | -6.9 % |
| 2008 | Edwards Lifesciences Corp | Director | 171.8 K | -3.8 % |
| 2008 | Avery Dennison Corp. | Director | 171.7 K | -4.9 % |
| 2007 | Avery Dennison Corp. | Director | 180.7 K | 1.3 % |
| 2007 | Edwards Lifesciences Corp | Director | 178.5 K | -0.2 % |
| 2006 | Edwards Lifesciences Corp | Director | 178.8 K | - |
| 2006 | Avery Dennison Corp. | Director | 178.4 K | - |
| 2005 | Edwards Lifesciences Corp | Director | - | - |
| 2005 | Avery Dennison Corp. | Director | - | - |
| 2004 | Edwards Lifesciences Corp | Director | - | - |
| 2004 | Avery Dennison Corp. | Director | - | - |
| 2003 | Edwards Lifesciences Corp | Director | - | - |
| 2003 | Avery Dennison Corp. | Director | - | - |
| 2002 | Edwards Lifesciences Corp | Director | - | - |
| 2002 | Avery Dennison Corp. | Director | - | - |
| 2001 | Edwards Lifesciences Corp | Director | - | - |
| 2001 | Avery Dennison Corp. | Director | - | - |
| 2000 | Edwards Lifesciences Corp | Director | - | - |
| 2000 | Avery Dennison Corp. | Director | - | - |